Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) is an expanding condition affecting a large population worldwide, with a significant proportion of these patients progressing to kidney failure and requiring considerations such as hemodialysis (HD). HD presents several challenges, such as an inflexible treatment regimen and limited toxin removal. Recent advancements have confirmed the use of adsorbents to increase the efficiency of the dialysis process. In the present research, adsorbents composed of polylactic acid (PLA) nanofibers containing activated carbon nanoparticles (AC NPs) were designed. Formation of uniform PLA nanofibers and presence of AC NPs on the surface of PLA nanofibers were evidenced. According to roughness evaluation, surface roughness of the prepared adsorbent was beyond the threshold of hemolysis, platelet and protein adhesion, and activation of the coagulation cascade. In addition, despite the enhanced surface hydrophilicity of the nanofibrous structure containing AC NPs, according to partial thromboplastin time test, the prepared adsorbent did not accelerate the clot formation. Evaluation of the fabricated nanostructural adsorbents for uremic toxin removal revealed high equilibrium adsorption and significant removal percentage. PLA nanofibrous mat containing 10 wt% AC NPs (possessing total weight of 3.5 mg), removed 31% of hippuric acid content and 90.5% of urea from the exposed solution and provided equilibrium adsorption capacity of 0.2 and 2.41 for the mentioned toxins, respectively. Adsorbents composition together with their unique microstructure providing high surface area and dual size porosity would account for the observed efficiency in uremic toxin removal.
No takes yet. Share an insight, caveat, or question.
Javadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: